Prof. Juan L. Antón-Pacheco is a senior Consultant pediatric surgeon in the Hospital Universitario 12 de Octubre of Madrid and Head of the Pediatric Airway Unit. Associate Professor of Pediatrics and Pediatric Surgery since 2005 (Universidad Complutense de Madrid).
Director, together with Prof. Robert E. Wood, of the “Pediatric Flexible Bronchoscopy Course”, Madrid venue, since 2010. Scientific background includes more than 100 articles published in indexed journals and 17 written book chapters. Research work is focused on new alternatives in the management of airway stenosis; quality of life in patients with obstructive central airway diseases; and the physiological response to airway stenting. Invited Visiting Professor in several hospitals and institutions in Europe and the U.S. Member of several national and international scientific associations : ERS, EACTS, SECP, SENP, Neumomadrid.
Prof. Andrew Bush is the Professor of Paediatrics and Head of Section (Paediatrics), Imperial College, Professor of Paediatric Respirology, National Heart and Lung Institute, and Consultant Paediatric Chest Physician, Royal Brompton Hospital, London UK. He is also Editor in Chief of Thorax, with Professor Ian Pavord.
His main research interests are the invasive and non-invasive assessment of airway inflammation, paediatric clinical physiology, and orphan lung diseases.
See more info about Prof. Andrew Bush here
Associate Professor Catherine (Cass) Byrnes MBChB, FRACP, GCCE, MD is an Associate Professor in the Paediatric Department at the University of Auckland and a Paediatric Respiratory Specialist at the Starship Children’s Hospital, Auckland, New Zealand. She completed her medical training in New Zealand, neonatal training at John Radcliffe Hospital Oxford and respiratory specialist training at the Royal Brompton Hospital & National Heart and Lung Institute in London where she completed her MD thesis. In her University role, she leads a research programme focused on improving outcomes of early childhood infection, recurrent pneumonias, bronchiectasis and cystic fibrosis - especially improving care of indigenous children - with 8 international collaborations and findings translated to changes in medical care. She was the Director of Undergraduate Medical School Paediatric Teaching for 6 years and is currently the Director of the FRACP paediatric programme in NZ. At Starship Children’s Hospital, she developed new national services (outreach, fibreoptic bronchoscopy, bronchiectasis, home ventilation/oxygen) and continues to lead bronchiectasis and cystic fibrosis care. She is the Chair of the PORT CF registry development and is on the editorial board of the New Zealand Formulary for Children.
Andrew Colin, MD is the Batchelor Professor of Cystic Fibrosis and Pediatric Pulmonology and Chief of the Division of Pediatric Pulmonology, Miller School of Medicine of the University of Miami. He has continually held leadership positions with the International Congresses of Pediatric Pulmonology (CIPP) and served as the President of its 10th and 11th Congresses.
Professor Colin completed fellowships in pediatric pulmonology at Hadassah Medical Center in Jerusalem and Boston Children's Hospital/Harvard Medical School. He remained at Harvard for 15 years ranked Associate Professor, and at Boston Children’s Hospital served as Clinical Chief of the pulmonary program, he was also in charge of the Pediatric Pulmonary Clerkship of Harvard Medical School.
Dr. Colin published extensively and presented nationally and internationally in areas of his interest: structural and functional development and morbidity of the respiratory system with related physiological measurements, including lung diseases of late prematurity, infants with CF and HIV. Pediatric bronchoscopy. Infectious and inflammatory diseases of the lung. Pediatric Radiology.
He directs the fellowship training program at the University of Miami and trained some 60 fellows in pediatric pulmonology. In 2017, he became the first ever recipient of “PEDS Lifetime Contributions to Pediatric Respiratory Medicine Award” of the ATS Assembly on Pediatrics. At Harvard, he received a Pulmonology Teaching Award named after him, as well as the 2004 Klaus Peter International Teaching Award. He has been named Honorary Fellow of the pediatric pulmonary societies of Philippines, Hong Kong and Thailand.
Adnan Custovic is Clinical Professor of Paediatric Allergy at Imperial College London. His research has focused upon the origins and natural history of asthma and allergy across the life-course, with an emphasis on prevention and translation for patient benefit. His research findings are of great practical significance, and have informed and changed national and international guidelines on asthma prevention/management. His current research programme combines world-leading expertise in birth cohorts and statistical machine learning, and capitalises on the recent developments within the field of computer sciences to provide powerful new tools that are well suited to the challenge of integration of different scales of data (from molecular-level to population-level), and different levels of directness of measurement of factors.
In 2015 Prof Custovic was awarded the highly competitive European Respiratory Society Gold Medal for research in asthma. In 2013 he received the BSACI William Frankland Medal for outstanding contributions to clinical allergy, and the CIPP President’s award for the distinguished achievements in childhood asthma. He delivered numerous prestigious keynote/named lectures, including Nemacolin Asthma Conference (2014), Alain De Weck Memorial Lecture (2013), Cas Motala Memorial Lecture (South African Allergy Society, 2013), James Hutchison's Memorial Lecture (Hong Kong Paediatric Society, 2012), the RSM Priscilla Piper Lecture (2011) and Caspar Weinberg Lecture (2007).
He has served as a Secretary of the BSACI for two terms, and as President of Asthma section of the EAACI.
Renato Cutrera, MD, PhD, graduated in Medicine at the University of Rome La Sapienza in 1981, and obtained the board in pediatrics and in respiratory diseases in 1985 and 1994, respectively.
He is, since 2000, head of the Pediatric Pulmonology Unit, Respiratory Intermediate Care Unit, Sleep and PLTVU at the Pediatric Hospital “Bambino Gesù” in Rome. The main fields of his clinical activity concern severe asthma, acute, chronic and congenital respiratory disorders in children and adolescents, non-invasive mechanical ventilation, in particular for children with severe neuromuscular diseases, Congenital Central Hypoventilation Syndrome and other rare respiratory conditions in children.
Dr Cutrera is author of over 100 scientific articles in various fields of research on pediatric disorders
Michael D. Davis, RRT, PhD is an Assistant Professor of Pediatrics at the Medical College of Virginia at Virginia Commonwealth University (MCV/VCU) in Richmond, Virginia. Prof Davis is a respiratory care practitioner who specialized in the development and implementation of exhaled biomarkers at the University of Virginia prior to pursuing a doctorate in Physiology and Biophysics at MCV/VCU. He is accredited in respiratory care practice in both the USA and Liberia. He lives and works in Liberia three months per year where he opened the first college of respiratory care in West Africa.
Dr. Davis is a member of the International Association of Breath Research and sits on the Global Task Force for Breath Standardization. He has published several manuscripts on the breath biomarker collection, analysis, and novel applications and currently oversees translational research projects involving exhaled biomarkers at five academic medical centers.
Dr Louise Fleming is a Clinical Senior Lecturer in Respiratory Paediatrics at the National Heart and Lung Institute and Consultant Respiratory Paediatrician at the Royal Brompton Hospital with a clinical and research interest in children with problematic asthma.
Dr Fleming’s research interests include distinguishing difficult from severe therapy resistant asthma, phenotyping severe asthma, interventions for problematic severe asthma and the use of biomarkers in asthma and pre school wheeze. She is the clinical lead for asthma at the Royal Brompton where she has developed the difficult asthma protocol and the National Registry for children with difficult asthma. She is a member of the BTS Specialist Advisory Group for Severe Asthma, a member of the BTS/SIGN clinical guidelines group and Chair of the Asthma UK Health Professionals Council.
Dr. David Gómez-Pastrana is a consultant in Pediatric Pulmonolgy at Jerez Hospital and Associate professor of Pediatrics at Cadiz Univesity.
Accredited in 2011 by the ERS after passing the first ERS Hermes Exam (European Diploma in Paediatric Respiratory Medicine).
Several fellowships in the UK in paediatric pulmonology and cystic fibrosis.
Clinical and research interest include tuberculosis, sleep breathing disorders, cystic fibrosis and asthma
Member of the Steering Committee of the Spanish Pediatric Pulmonology Society and coordinates infections and tuberculosis working group of this Society.
Professor Jonathan Grigg is the leading UK paediatric expert on the health effects of air pollution on children. His research has identified why children are more at risk of adverse effects, and the mechanisms whereby inhalation of particles increases vulnerability to bacterial infection. These studies have informed the public on the risks of air pollution, and influenced national policy. He was also a lead author of the Royal College of Physicians’ Report on the long-term effects of air pollution. In the area of paediatric respiratory medicine, he has built up Applied Health Research Capacity in North London, attracting over £16 million in grant funding to address major health needs, including asthma in children, and has been lead clinician on major independent and industry trials of new and existing asthma therapies.
R. Paul Guillerman is Professor of Radiology at the Baylor College of Medicine and Chief of Academic Affairs in the Department of Pediatric Radiology at Texas Children’s Hospital in Houston, Texas. His clinical and research interests include imaging of pediatric diffuse lung diseases, chest CT technique optimization, risk assessment and communication. He has given over 130 invited lectures, authored or co-authored over 80 medical journal articles and textbook chapters, and co-edited the latest edition of the Springer textbook Pediatric Chest Imaging. He is co-director of the Center for Diagnostic Imaging of the Cystic Fibrosis Foundation (CFF) Therapeutic Development Network. He has served as a member of the CFF Preschool Age Screening and Monitoring Workgroup, Children’s Interstitial Lung Disease Research Network (ChILDRN), Image Gently Steering Committee and Speakers Group, Society for Pediatric Radiology (SPR) Research & Education Board of Directors, SPR CT and Thoracic Imaging Committees, and ACR-SCBT-MR-SPR Practice Guideline for the Performance of Thoracic CT Committee.
John Henderson is Professor of Paediatric Respiratory Medicine at the University of Bristol and Bristol Royal Hospital for Children, UK. He graduated from the University of Manchester and after training in paediatrics, he was a research fellow in Bristol, UK and Perth, Western Australia. He was awarded his MD by the University of Manchester in 1991. He returned to complete his training in paediatric respiratory and critical care medicine and was appointed as a consultant in paediatric respiratory medicine in 1993.
John’s main research interests are in the epidemiology of asthma and respiratory health in early life. He joined the Avon Longitudinal Study of Parents and Children in 1995. He is now Co-Director of ALSPAC and leads the respiratory and allergy programme. He has published over 150 papers and co-edited the Respiratory Disorders chapter in Forfar & Arneil’s Textbook of Pediatrics. He was formerly Deputy Editor of Archives of Disease of Childhood.
Michael Kabesch is full professor at Regensburg University in Germany and chief medical director of the University Mother and Child Hospital St. Hedwig, where he also heads the department of Pediatric Pneumology and Allergy. He is a pediatrician, pediatric pneumologist and allergologist and trained with Erika von Mutius in Munich and Fernando Martinez at the respiratory Center in Tucson Arizona.
His main research interests are early genetic and environmental factors associated with various respiratory diseases, allergy and immunity. He was involved in numerous large scale European research activities such as the GABRIEL consortium as well as the current HEALS and PICA consortia, publishing the first genome wide association studies on asthma and other atopic diseases. He was also one of the initial principle investigators establishing the German Lung Research Center (DZL). So far, his research led to more than 170 pubmed listed publications. Of the fellows he trained in his group, four have become professors themselves on 3 different continents.
Professor Mikhail Kazachkov is a Chief of the Division of Pediatric Pulmonology and Director of Gastroesophageal, Upper Airway and Respiratory Diseases (GUARD) Center at Hassenfeld Children’s Hospital at New York University, USA
Professor Kazachkov did his pediatric pulmonary training first in Saint Petersburg, Russia and later in University of North Carolina at Chapel Hill, USA. He obtained in-depth expertize in pediatric bronchoscopy, which defined his career, which is all dedicated to treating children with chronic cough, asthma, pneumonia, chronic bronchitis, and other respiratory conditions.
He often sees children with complex, or difficult-to-diagnose conditions, and takes care of them with his team from NYU Langone’s Pediatric Gastroesophageal, Upper Airway, and Respiratory Diseases (GUARD) Center. He has major interest and expertize in aerodigestive disorders and in management of neurologically impaired children with chronic respiratory problems. He serves as a Pulmonologist for Familial Dysautonomia Center at NYU.
Dr. Kazachkov’s research analyses causes of chronic cough in children. He studies aerodigestive disorders and actively participates in microbiome studies at NYU.
Prof. Eitan Kerem, MD, a world known leader in Cystic Fibrosis research, is a principal investigator of numerous national and international multicenter clinical trials. He is the author of seminal publications in the field, including phenotype-genotype relationships, disease prognostic factors, the molecular mechanisms for disease variability, and the development of novel mutation-specific pharmacological therapies to correct the basic defects in cystic fibrosis.
His many interests extend beyond cystic fibrosis, and he has been central to studies examining environmental interactions with genetic diseases and its influence on the disease severity, genetic markers of asthma and allergy in closed populations, and variability of disease in closed populations exposed to different environments. Increasingly, his efforts have turned to understanding the genetics of primary ciliary dyskinesia in Jewish and Palestinian children. In addition he published leading papers on management of community acquired pneumonia in children and was the first to characterize nectrotizing pneumonia and risk factors for complicated pneumonia in children.
The promotion of the medical, ethical and rights aspects of children with chronic diseases is at the forefront of his interest. He published many papers in this field and is known for his advocacy for children in need.
He also has a record of building bridges between Israelis and Palestinians furthering peace through medicine wherever possible.
Professor Kerem received a number of prestigious awards the last being the European CF Society Award in 2014.
He has authored over 170 papers covering all aspects of Pulmonology.
Prof. Amir Kugelman is a Clinical Associate Professor of Pediatrics in The R&B Rappaport Faculty of Medicine, Technion, Haifa, Israel. He specialized in Pediatric Pulmonology and Neonatology in Children's Hospital, LA, CA, and is currently the Director of the Department of Neonatology in Rambam Medical Center, Haifa, Israel and the past Chairman of the Israeli Society of Pediatric Pulmonology.
His main research is in Neonatal Pulmonology, focusing on non- invasive ventilation, non-invasive respiratory monitoring in the NICU and the Pediatric Department, and in the prevention and treatment of Chroric Lung Disease of premature infants. Other areas of interest and research: Iatrogenesis in NICUs, late preterm infants, outcome of VLBW infants, and delayed cord clamping in the delivery room.
Larry C. Lands, MD, PhD, is a tenured full professor in the Department of Pediatrics of McGill University, Director of Pediatric Respiratory Medicine and Director of the Cystic Fibrosis Clinic at the Montreal Children’s Hospital. His research interests focus on modulation of inflammation and enhancing functional capacity in Cystic Fibrosis and severe asthma, with over 125 peer-reviewed articles. Dr. Lands is Chair of Cystic Fibrosis Canada’s Research Advisory Council. He is Chair of the Research Committee of the Canadian Thoracic Society and Associate Director of the Respiratory Health Research Network of the Fonds de Recherche du Québec-Santé. Dr. Lands chairs the Studentship and Fellowship adjudication committees of the Lung Association (Canada). He is on the editorial boards of Paediatric Respiratory Reviews and F1000. Dr. Lands is co-inventor of fenretinide as a novel anti-inflammatory therapy for Cystic Fibrosis, under development by Laurent Phamraceuticals.
Dr. Enrico Lombardi, MD graduated in Medicine from the University of Florence, Italy, in 1991. From 1995 to 1996 he was a research associate in Tucson, Arizona, where he worked and published in the fields of lung function testing in young children and the epidemiology of pediatric asthma. He completed his residency in Pediatrics in 1997 in Florence, where in 2001 he took a position as Pediatrician at the “Anna Meyer” Children’s Hospital. In 2006 he completed the specialization in Diseases of the Respiratory System and since then he is in charge of the Pediatric Pulmonary Unit at Meyer Children’s Hospital in Florence. Dr. Lombardi was the chair of the 7.1 Group “Paediatric Respiratory Physiology and Sleep” of the European Respiratory Society from 2012 to 2015 and chair of the International Relation Committee of the Pediatric Assembly of the American Thoracic Society from 2010 to 2016. His main area of interest is lung function testing in young children, on which he has published extensively and presented nationally and internationally.
Prof. Carmen Luna-Paredes obtained her PhD in 2009 with a thesis on the prevalence of snoring and other symptoms of sleep apnea in an urban Area in Madrid, Spain. Since 1998 she works at Hospital Universitario 12 de Octubre, Madrid, where she did her Paediatric training and where she currently coordinates the Paediatric Respiratory Medicine and Allergy Section and is a funding member of the Paediatric Airway Unit. She holds a position as Associate Professor and is affiliated with the Department of Paediatrics of the Universidad Complutense de Madrid. Her clinical practice and main research interest focus on chronic conditions such as cystic fibrosis, severe craniofacial anomalies, children with neuromuscular diseases/or dependent on respiratory technologies. She has published a number of papers on these issues in international journals.
Dr. Fernando D. Martinez is a Regents’ Professor and Director of the Asthma & Airway Disease Research Center at the University of Arizona in Tucson.
Dr. Martinez is a world-renowned expert, and one of the most highly regarded researchers, in the field of childhood asthma. His primary research interests are the natural history, genetics, and treatment of childhood asthma.
His groundbreaking research has had an impact on his field in numerous ways, most prominent among them the development of the concept of the early origins of asthma and COPD. This concept is now widely accepted as the potential basis for the design of new strategies for the prevention of these devastating illnesses affecting millions of children and adults worldwide. In addition, Dr. Martinez has made important contributions to our understanding of the role of gene-environment interactions in the development of asthma and allergies. He has also been the principal investigator of one of the Clinical Centers that are part of the NHLBI Asthma Treatment Networks, which have contributed fundamental new evidence on which to base national guidelines for the treatment of the disease.
Dr. Martinez currently serves on national scientific boards including the NHLBI National Advisory Council and the National Scientific Council on the Developing Child. He was a member of the National Asthma Education and Prevention Program that was responsible for the development of the Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma in 1997 and its first revision in 2001. He also has been a member of the FDA Pulmonary-Allergy Drugs Advisory Committee and the Board of Extramural Advisors of the National Heart, Lung, and Blood Institute (NHLBI).
Dr. Martinez’s research and vision are well detailed in more than 250 original research papers and editorials, many in collaboration with investigators from all over the world. He is frequently invited to give keynote presentations at national and international meetings.
Dr. Luis Moral, MD, Ph.D. is a clinical Pediatrician leading the Pediatric Allergy and Respiratory Unit of the University General Hospital of Alicante (Spain) and the chairman of the Pediatric Research Group of the Institute of Sanitary and Biomedical Research of Alicante (ISABIAL). He is also the chairman of the Working Group on Respiratory Allergy and Asthma of the Spanish Society of Pediatric Clinical Immunology, Allergy and Asthma (SEICAP) and a member of the Spanish Society or Pediatric Pulmonology (SENP).
The main fields of his clinical activity and expertise/research concern (1) Pediatric asthma: concept and diagnosis; (2) Asthma in the preescholer; (3) Pleural effusion and empyema; (4) Influenza in children; (5) Drug allergy in children; (6) Tobacco in Pediatrics. He is particularly interested in simplifying clinical medicine and avoiding over medicalization (diagnosis and treatment) of pediatric practice.
Dr. Moral is author of over 40 scientific articles in various fields of research on pediatric disorders.
Dr. Antonio Moreno Galdó was born in Granada (Spain) and graduated in Medicine at the Faculty of Medicine of the University of Granada in 1983.
He completed his specialty in Pediatrics at Hospital Universitario Vall d’Hebron in Barcelona, Spain in 1988, and his doctoral thesis at Universitat Autònoma de Barcelona, in 1992.
He worked as an assistant physician in the Pediatric Department of Hospital Son Dureta in Palma de Mallorca, Spain, between 1989 and 1992 and since 1992 he works at Hospital Universitario Vall d’Hebron in Barcelona, Spain.
Between 1989 and 1997 his professional dedication was directed to Pediatric Intensive Care and since 1998 he specialized in Pediatric Pulmonology. He is currently the Head of the Allergy, Pediatric Pulmonology and Cystic Fibrosis Section of Hospital Universitario Vall d’Hebron in Barcelona. Dr. Moreno is the Medical director of the children's lung transplant program that began in 1998.
Since 2006, he has been an Assistant Professor of Pediatrics and since 2014 he is Associate professor of Pediatrics at the Autonomous University of Barcelona.
His main areas of interest and research, include rare lung diseases in children such as interstitial lung diseases, pulmonary hypertension and primary ciliary dyskinesia; pulmonary inflammation in asthma in infants and school children, and lung function in children.
Prof. Petr Pohunek, MD PhD FCCP. Head, Division of Pediatric Respiratory Diseases, Pediatric Department, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
Chairman of the Czech Society for Pediatric Pulmonology.
Chairman, Group 7.7 (Pediatric Bronchology) of the Pediatric Assembly of the European Respiratory Society.
Main research interest: Pediatric Asthma; Primary ciliary dyskinesia; Pediatric chronic respiratory diseases.
Dr Martí Pons is consultant paediatrician for pediatric intensive care in Hospital Sant Joan de Déu, one of the largest paediatric teaching hospitals in Spain. He is also in charge of the Home ventilation program.
Graduated from Medical School at Barcelona University in 1990,Martí did his PhD research in the same university, and defended his thesis about “non-invasive ventilation in the acute setting” cum laude. He was trained in Paediatrics and did his fellowship in Paediatric Intensive Care at Hospital Sant Joan de Deú were exerts his current position as a consultant.
Dr. Pons’s clinical interests include respiratory care in critical care. Active areas of research include mechanical ventilation, mainly focused on non invasive ventilation (NIV). Martí has contributed to more than 40 articles in peer-reviewed journals, and has edited three books on paediatric non-invasive ventilation. Recently has launched, the third edition written in collaboration with Dr Medina, Martinón-Torres, Gili and Mayordomo-Colunga.
Dr. Pons is member of Respiratory working group of Spanish PICU society and ESPNIC (European society). Last eight years has participated in many international meetings and organized several courses promoting NIV use in acute and also chronic pediatric patient.
Prof. Jean-Paul Praud is a Pediatric Pulmonologist at the Sherbrooke University Hospital, Quebec, Canada, and Director, Center for Research into Maternal and Child Health, University of Sherbrooke. He holds the Canada Research Chair in Neonatal Respiratory Physiology since 2009.
He was co-founder of CIPP and Past-President, CIPP V. He has been President, ICPP-The Course, since 2007. He was a member of the Central Organizing Committee of all CIPP meetings and ICPP-Courses.
He is internationally renowned for his unique research contributions in the field of neonatal respiration, nasal respiratory support and sleep apneas.
Giovanni A. Rossi is the former chief of the Pulmonary and Allergy Units and of the Cystic Fibrosis Centre at the G. Gaslini Research Institute and University Hospital in Genoa and the former adjunct Professor of Paediatric Pulmonology at the University of Genoa, Italy. He is at present Chief Emeritus at the Gaslini Research Institute and University Hospital.
He graduated from the University of Genoa, Italy and trained in Respiratory Medicine at the San Martino University Hospital, in Genoa, and then at the Pulmonary Branch of the National Institutes of Health in Bethesda, U.S.A., as Visiting Associate.
Dr. Rossi was Member of the Executive Committee of the Société Européenne de Physiologie Clinique Respiratoire, Chairman of the "Lung Cell Biology" Assembly of the European Respiratory Society (ERS), Member of the ERS Executive Committee, society of which he has been recently appointed “Foundation Fellow”. He also served as an Associate Editor on the Editorial Boards of several respiratory, allergy and pediatric journals. He has published >300 manuscripts in peer reviewed journals and has at present a H. index of 52.
Dr. Rossi’s major areas of basic and clinical research have been the mechanisms involved in the pathogenesis of a variety of respiratory disorders, including interstitial, obstructive and infectious diseases. In this last field, his work has focused mainly on the characterization of the host-virus interaction at lower respiratory tract level, with the aim of developing novel strategies for the prevention and treatment of these high-impact respiratory disorders for which specific therapies are often not yet available.
Prof. Bruce Rubin is the Jessie Ball duPont Distinguished Professor and Chair of Pediatrics at Virginia Commonwealth University in Richmond, Virginia and Physician in Chief of the Children’s Hospital of Richmond. He is also Professor of Biomedical Engineering and Adjunct Professor of Physiology and Biophysics at VCU. Prof Rubin is a pediatric pulmonary physician and a Fellow of the Royal Society of Physicians of Canada (FRCPC). As a Rhodes Scholar, he trained as a post doc in Biomedical Engineering at Oxford University and in Paediatric Respirology at Sick Kids in Toronto. He holds the MD and Masters in Engineering degrees from Tulane and an MBA degree from Wake Forest University School of Business.
Dr. Rubin received the 2008 Forrest M. Bird Lifetime Scientific Achievement Award, the top research honor given by the American Association for Respiratory Care (AARC), in 2011 he presented the Phil Kittredge Memorial Keynote lecture at the AARC in 2012, he was awarded Jimmy Young Memorial medal from the AARC. He holds honorary appointments in 4 medical schools. He is on the editorial board of 12 medical journals, has published more than 300 original research papers and chapters and holds nine patents. Dr. Rubin and his research team study aerosol therapy for lung diseases, airway inflammation and excessive mucus that contributes to lung disease.
He is also an accomplished magician, an elected member of the International Brotherhood of Magicians, and over the past 25 years had taught medical magic in 30 countries on 5 continents.
Sejal Saglani is Reader in Paediatric Respiratory Medicine at the National Heart & Lung Institute, Imperial College London and Honorary Consultant in Respiratory Paediatrics, Royal Brompton Hospital, London.
The focus of her research includes: 1) mechanisms underlying the development of wheezing disorders in preschool children and factors that determine progression to childhood asthma, and management of preschool wheezing using inflammatory and infective airway phenotypes. 2) Diagnosis and management of paediatric severe therapy resistant asthma and mechanisms mediating the pathophysiology of severe disease to determine novel therapeutic targets.
She runs a translational research programme incorporating a neonatal murine model of inhaled allergen exposure and bronchoscopic airway samples from children with severe wheezing and asthma.
Dr Thomas Semple is a cardiothoracic and paediatric radiologist, working between the Royal Brompton and Great Ormond Street hospitals, in London. He gained an interest in paediatric thoracic and cardiac imaging whilst working with Dr Catherine Owens at Great Ormond Street hospital and is currently undertaking an MDres degree at the National Heart and Lung Institute, Imperial College London, under the supervision of Professors Simon Padley, Claire Hogg and Jane Davies.
His research interests include the application of respiratory MRI techniques to paediatric imaging (particularly Fourier decomposition and oxygen-enhanced ventilatory imaging), CT imaging of childhood interstitial lung disease, complex congenital heart disease and paediatric CT dose optimisation.
Dr Varinder Singh, Director Professor of Pediatrics, Lady Hardinge Medical College and Assoc Kalawati Saran Children’s Hospital, N Delhi, INDIA
He trained at the prestigious Maulana Azad Medical College at N Delhi. He had the opportunity to work with the Pediatric Chest Disease unit at their leading Lok Nayak Hospital for 6 years before he joined as a Pediatric Consultant at the National Institute of TB and Respiratory Diseases at Delhi. This position helped him to sharpen his skills of respirology and TB. He led the pediatric services in this hospital for 5 years; during which time he also coordinated the massive training effort of the Country’s TB programme. He then moved on to the current Institute to follow his passion of clinical teaching and research in 1998. He is recipient of the Commonwealth Academic staff fellowship in 2003 under Prof Andrew Bush at Royal Brompton Hospital, London, UK. He currently runs the respiratory and bronchoscopy services at a major children’s hospital at Delhi. He has been instrumental in developing regional and National guidelines on Asthma, TB and Respiratory Infections. He is currently championing the cause of Rational Antimicrobial use. He has been in leadership position for the Indian Academy of Paediatrics National Respiratory Chapter and is a founder member of Asian Pediatric Pulmonary Society. He is member of the Editorial Board of -Pediatric Respiratory Review, Indian Pediatrics, etc. He has been time and again involved with CIPP as a faculty since 2006.
Professor Peter Sly is the Deputy Director, Queensland Children's Medical Research Institute, Director, Children's Health and Environment Program and Director, WHO Collaborating Centre for Children's Health and Environment. Professor Sly is a NHMRC Senior Principal Research Fellow and a paediatric respiratory physician with extensive research experience in respiratory physiology, developmental immunology and children's environmental health. Professor Sly’s research aims to understand the mechanisms underlying chronic childhood lung diseases in order to improve clinical management and to delay or prevent their onset, with consequent reductions in adult lung diseases. A combination of basic science, longitudinal cohort studies and translation of research findings into clinical practice, including clinical trials, are included in three main areas: asthma, cystic fibrosis and children’s environmental health
Dr. Manuel E. Soto-Martínez is an Assistant Professor of Paediatrics and Paediatric Pulmonology, School of Medicine of the University of Costa Rica. Graduated in Paediatrics from the University of Costa Rica in 2007. From 2007 to 2010 he completed his fellowship in respiratory medicine at the Royal Children´s Hospital in Melbourne, Victoria, Australia. In addition, he completed his Masters in Epidemiology at the National University of Costa Rica (2013-2015). He is currently a Paediatric Respiratory Physician and Sleep Physician at the Respiratory Department, Hospital Nacional de Niños, San José, Costa Rica.
His areas of expertise/research:
- - Paediatric Ashtma: severe asthma, asthma epidemiology
- - Respiratory infections
- - Paediatric bronchoscopy
- - Cystic Fibrosis
- - Non-Invasive ventilation, home oxygen
- - Respiratory related Sleep Disturbances
- - Respiratory Complications in Neuromuscular disease
- - Member of the American Thoracic Society
- - Member of the European Respiratory Society
- - Member of Asociación Latinoamericana de Tórax (ALAT)
- - Member of Asociación Costarricense de Tórax
- - Consultant in Respiratory Medicine, Hospital Nacional de Niños, San José, Costa Rica
- - Coordinator Home Ventilation Program, Hospital Nacional de Niños, San José, Costa Rica.
- - A/Prof. Pediatrics, School of Medicine, Universidad de Costa Rica
- - Member of the Postgraduate in Paediatrics’ Academic Committee, Universidad de Costa Rica
Renato T. Stein, MD, MPH, PhD graduated in Medicine in 1979 from Pontifícia Universidade Católica, in Porto Alegre, Brazil where he completed his residency in Pediatrics in 1982. He took over as Assistant Professor at the Department of Pediatrics in 1986, and from 1987 to 1989 was a fellow in the Pediatric Pulmonary Service in Toronto, at The Hospital for Sick Children. In 1994 Dr. Stein took a position as a research fellow in Tucson, Arizona, where he worked with the Children’s Respiratory Study cohort, publishing in the field of risk factors related to asthma in children. In 2011 he did a 6 months sabaticcal in the Center for Environmental Epidemiology, in Barcelona, Spain. In Brazil Dr. Stein has been leading a large and productive group of researchers at his Institution. His main areas of interest are the relation between respiratory viruses and recurrent wheeze, asthma phenotypes, impact of the environment on respiratory health, and respiratory disease of preterm infants.
Dr. Stanley J. Szefler’s major contributions are directed toward the individualized use of asthma therapy. He has identified biomarkers and asthma characteristics that are associated with asthma exacerbations and response to asthma therapy. He is currently the Research Medical Director and Director of the Pediatric Asthma Research Program in the Breathing Institute of the Pediatric Pulmonary Section at Children’s Hospital Colorado. He is also Professor of Pediatrics at the University of Colorado Denver School of Medicine.
Since 1997, he has been the Deputy Editor for the Journal of Allergy and Clinical Immunology. He is a former member of the Global Initiative for Asthma Science Committee and a former member of the Expert Panel for the National Heart, Lung, and Blood Institute’s National Asthma Education and Prevention Program on “Guidelines for the Diagnosis and Management of Asthma”. He is also the Co-Principal Investigator for the Denver site of the NHLBI AsthmaNet and NHLBI PrecISE.
For the past twelve years, he has developed a school-centered asthma program funded by the Colorado Department of Public Health and Environment Cancer, Cardiovascular and Pulmonary Disease Program and Glaxo Smith Kline. This program identifies those students most significantly affected by asthma, establishes lines of communication between schools, primary care physicians, and specialists to assure that these children have consistent medical care.
Dr Hui-leng Tan is a Consultant in Paediatric Respiratory and Sleep Medicine at the Royal Brompton Hospital and Honorary Senior Lecturer, Imperial College, London. She completed her paediatric respiratory training at Royal Brompton Hospital and Great Ormond Street Hospitals and her sleep fellowship at the University of Chicago. Her research interests are in Sleep disordered breathing in children.
Alexander Ocampo Tuazon, MD, MDE. Philippine Board certified in Pediatrics and Pediatric Pulmonology, active in teaching, research and clinical practice. A holder of a Master in Distance Education. Professor in Pediatrics, past Director of the Institute of Child Health and Human Development, University of the Philippines Manila. Current Head, Section of Pediatric Pulmonology at the College of Medicine, University of the Philippines Manila, Vice President of the Philippine Pediatric Society and Member of the Philippine Subspecialty Board in Pediatric Pulmonology. Research interests include asthma, pulmonary infections and pulmonary physiology. Has published with book chapters, consensus statements on asthma, and research articles both in the Philippines and in international publications. An officer and member in a number of professional organizations involved in pediatrics, pediatric pulmonology, asthma, pharmacology, and pharmaceutical medicine. Contact Address: Section of Pulmonology, Department of Pediatrics, Philippine General Hospital, Taft Avenue, Manila, Philippines.
Prof. Stijn Verhulst, MD, PhD is professor in pediatrics at the University of Antwerp, Belgium and head of the pediatric pulmonoly and sleep unit at the Antwerp University Hospital. He is also director of the Antwerp Cystic Fibrosis Center and consultant at Inkendaal Hospital, Belgium. His research mainly focuses on the complications and management of sleep-disordered breathing in children. He was co-chair of a European Respiratory Society Task force on obstructive sleep apnea in children. More recently, he started several new research projects in non-invasive ventilation, BPD and cystic fibrosis. He is author or co-author of more than 90 papers and book chapters in national and international journals.
Professor Gary Wong obtained his undergraduate medical education from the University of Alberta, Canada. He subsequently received fellowship training at University of British Columbia, and Children’s Hospital of British Columbia and visiting Fellowship at the Children’s Hospital at Munich, Germany.
Dr Wong’s main research interests are treatment and prevention and control of asthma, and respiratory infections. He is the current President of the Asia-Pacific Association of Pediatric Allergy, Respirology and Immunology (APAPARI). He has been one of the Board of Directors of the Global Initiative for Asthma (GINA) and one of the GINA Assembly members since 2008. He is one of the steering committee members of the ISAAC (International Study of Asthma and Allergies in Childhood) research group. He has published over 230 original articles, review papers, and book chapters in the field of asthma and related atopic conditions. Among other duties within several editorial boards, he is also an associate editor of New England Journal of Medicine, and one of the Section Editors of Pediatric Allergy and Immunology.
Current Post: Professor and honorary consultant, Department of Paediatrics and School of Public Health, Faculty of Medicine, Chinese University of Hong Kong, Hong Kong
Heather Zar is Professor and Chair of the Department of Paediatrics and Child Health, Director of the School of Child and Adolescent Health at Red Cross Childrens Hospital at the University of Cape Town (UCT), South Africa. After specialising in Paediatrics she did a fellowship in Paediatric Pulmonology, then a PhD. She is based at Red Cross Childrens Hospital, one of the largest dedicated childrens’ hospital in Africa. She leads a large department in providing care for sick children, training of undergraduate and post graduate students, undertaking research and advocacy to promote child health. Her work on childhood respiratory diseases, including tuberculosis, pneumonia, asthma and HIV-associated lung diseases has been internationally recognized; she has published more than 200 peer reviewed publications and has substantial international grant support. She has established a strong training program in childhood lung diseases including training several paediatricians in Africa. She currently serves as President of the Pan African Thoracic Society and President of the Forum of International Respiratory Societies. She received the World Lung Health award in 2014.